CHANGING THE WORLD BILLIONS OF CELLS AT A TIME Logo (WIPO, 08/12/2019)
WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark CHANGING THE WORLD BILLIONS OF CELLS AT A TIME was filed as Word mark on 08/12/2019 at the World Intellectual Property Organization.
| Trademark form | Word mark |
| File reference | 1513190 |
| Countries | 
|
| Base trademark |
No. 88320219,
February 28, 2019
|
| Application date | August 12, 2019 |
| Expiration date | August 12, 2029 |
Trademark owner
Paasheuvelweg 25A
1105 BP Amsterdam
NL
1105 BP Amsterdam
NL
goods and services
05
Pharmaceutical preparations for the treatment of immuno
oncological disorders, cancer, diabetes, respiratory, heart,
neurological and auto immune disorders; stem cells for
medical purposes; living cells for medical use; biological
preparations for the treatment of cancer; therapeutic
pharmaceuticals utilizing neural crest cells for use in the
treatment of cancer, autoimmune disease and infectious
diseases; cell preparations, cellular vaccines and cellular
biologics for the treatment of cancer and infectious
diseases by autologous cell-based immunotherapy
42
Scientific and technological services, namely, scientific
research, design, analysis and testing in the field of
cancer evolution and new cancer therapies using natural
killer cells; industrial research in the field of new
pharmaceutical products and new cancer therapies; medical
and veterinary research services in the nature of the
manipulation of cells within a laboratory or research
facility to enable natural killer cells to be used for
medical or therapeutic purposes; scientific research in the
development of new cancer therapies; scientific research in
human and animal cell therapy; scientific research into
preparations for manipulating and adapting human and animal
cells; consultancy relating to all the aforesaid services;
conducting research and clinical trials for others relating
to the use and the engineering of natural killer cells and
cancer treatment and therapy; medical and scientific
research in the field of cancer treatment and diagnosis;
data collection for others for research purposes, namely,
the collection, testing and research of patient molecular
and genomic data (term considered too vague by the
International Bureau - Rule 13 (2) (b) of the Common
Regulations); collection and preservation of human and
animal DNA for research purposes; providing a website
featuring health and healthcare information related to
cancer research (term considered too vague by the
International Bureau - Rule 13 (2) (b) of the Common
Regulations)
44
Medical testing for diagnostic or treatment purposes in the
field of cancer research; medical diagnostic testing,
monitoring and reporting services; medical evaluation of
immuno oncological disorders, cancer, diabetes, respiratory,
heart, neurological and auto immune disorders; medical
monitoring services; medical diagnostic, prognostic and
theranostic screening and testing services; collection and
preservation of DNA for medical purposes; consulting
services in the nature of providing medical information;
consulting services in the field of healthcare and cancer
diagnoses; providing a website featuring health and
healthcare information related to cancer, testing and
screening (term considered too vague by the International
Bureau - Rule 13 (2) (b) of the Common Regulations); genetic
testing for medical purposes; providing information in the
field of cancer prevention, screening, diagnosis and
treatment for medical diagnostic and treatment purposes;
providing genetics assessments in the nature of genetic
counseling; genetic testing for medical diagnostic purposes;
genomic testing for medical diagnostic purposes; gene
analysis and sequencing and DNA analysis and sequencing for
medical diagnostic purposes and veterinary diagnostics
purposes; gene analysis and sequencing and DNA analysis and
sequencing for use in cancer diagnosis and treatment
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| August 24, 2022 | 2022/37 Gaz | US | RAW: Partial Ceasing Effect |
| March 8, 2022 | 2022/11 Gaz | CA | Rejection |
| November 3, 2021 | 2022/7 Gaz | AU | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| August 19, 2021 | 2022/12 Gaz | JP | RAW: Second Part Fee Not Paid |
| August 19, 2021 | 2021/34 Gaz | JP | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| July 5, 2021 | 2021/27 Gaz | KR | Rejection |
| June 15, 2021 | 2021/28 Gaz | SG | Rejection |
| May 26, 2021 | 2021/22 Gaz | CA | Rejection |
| March 25, 2021 | 2021/12 Gaz | JP | Rejection |
| March 9, 2021 | 2021/11 Gaz | SG | RAW: Refusal Transfer of Ownership |
| January 27, 2021 | 2021/5 Gaz | KR | Rejection |
| June 26, 2020 | 2020/27 Gaz | EM | Rejection |
| May 28, 2020 | 2020/23 Gaz | CN | Rejection |
| May 22, 2020 | 2020/22 Gaz | AU | Rejection |
| March 19, 2020 | 2020/12 Gaz | SG | Rejection |
| February 15, 2020 | 2020/8 Gaz | GB | Rejection |
| August 12, 2019 | 2020/4 Gaz | US | Registration |
ID: 141513190